SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare informs about voting results of AGM

21 Sep 2022 Evaluate

As per the requirement of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Themis Medicare has informed that it enclosed the details of the voting results of the 52nd Annual General Meeting (AGM) of the Company, held on Monday, 19th September, 2022 which commenced at 12.01 pm and concluded at 12.40 pm through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM') as per the prescribed format under the said regulation. Further, consolidated Scrutinizer’s Report on remote e-voting and e-voting at the AGM also enclosed. Consider this as compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

90.00 -0.25 (-0.28%)
20-Apr-2026 11:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1238.10
Cipla 1239.20
Zydus Lifesciences 942.70
Lupin 2325.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×